| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.03.23 | Vimian Group: Vimian's year-end report for 2022 | 216 | GlobeNewswire (Europe) | Solid year in challenging macroeconomy
Revenue increased by 62 per cent to EUR 281.3m (173.3), of which 3.7 per cent was organic growth (8.7 per cent excluding Diagnostics)Adjusted EBITA EUR 73.4m... ► Artikel lesen | |
| 08.03.23 | Voltalia SA: First power generation for Helexia in Brazil | 940 | GlobeNewswire (Europe) | Helexia, a subsidiary of Voltalia (Euronext Paris, ISIN code: FR0011995588) and an international player in the energy transition, announces its first Brazilian distributed generation solar assets began... ► Artikel lesen | |
| 08.03.23 | Arctic Fox Minerals Corp. Announces Name Change, Consolidation and Symbol Change | 230 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, March 08, 2023 (GLOBE NEWSWIRE) -- Arctic Fox Minerals Corp. (CSE: FOXY) (the "Company" or "Arctic Fox") announces that pursuant to receipt of shareholder's approval on... ► Artikel lesen | |
| 08.03.23 | mdxhealth: MDxHealth Reports Financial Year 2022 Results and Provides Business Update and Outlook for 2023 | 285 | GlobeNewswire (Europe) | NEWS RELEASE - REGULATED INFORMATION8 MARCH 2023, 4:00 PM EST / 22:00 CET Conference call with Q&A today at 4:30 PM EST / 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM - March 8, 2023 - MDxHealth SA... ► Artikel lesen | |
| 08.03.23 | Conifex Timber Inc: Conifex Announces 2022 Year-End and Fourth Quarter 2022 Results | 297 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, March 08, 2023 (GLOBE NEWSWIRE) -- Conifex Timber Inc. ("Conifex", "we" or "us") (TSX: CFF) today reported results for the fourth quarter and year ended December 31, 2022.... ► Artikel lesen | |
| 08.03.23 | Tenaya Therapeutics, Inc.: Tenaya Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update | 340 | GlobeNewswire (Europe) | TN-201 IND Cleared in January; Plan to Begin Phase 1b Dosing in MYBPC3-associated HCM Patients in Third Quarter 2023 Dosing Commenced in Multiple-Ascending Dose Stage of First-In-Human Clinical Trial... ► Artikel lesen | |
| 08.03.23 | MISTRAS Group, Inc.: MISTRAS Announces Fourth Quarter and Full Year 2022 Results | 530 | GlobeNewswire (Europe) | Significantly Improved Quarterly Operating Profit and Net Income Growth Fourth quarter Gross Profit expands 130 basis points, Operating Income increases 152% 2022 Full Year Net Income of $6.5 million... ► Artikel lesen | |
| 08.03.23 | OptimizeRx Corporation: OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results | 281 | GlobeNewswire (Europe) | Q4 revenue of $19.7 million, down 3% year-over-year and up 30% quarter-over-quarterQ4 gross profit increased 1% year-over-year to $12.5 million as gross margins increased from 61% to 63%Generated $10.7... ► Artikel lesen | |
| 08.03.23 | Assertio Holdings, Inc.: Assertio Reports Fourth Quarter and Full Year 2022 Financial Results | 228 | GlobeNewswire (Europe) | Net Product Sales Increase 55% in the Fourth Quarter, 42% for the Full Year Full Year Net Income Increases to $109.6 Million, Non-GAAP Adjusted EBITDA Increases to $101.6 Million Cash Flows from Operations... ► Artikel lesen | |
| 08.03.23 | eFFECTOR Therapeutics, Inc.: eFFECTOR Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update | 931 | GlobeNewswire (Europe) | Zotatifin continued to demonstrate favorable activity and tolerability, including two previously reported confirmed partial responses (PRs) among seven heavily pretreated subjects who received zotatifin... ► Artikel lesen | |
| 08.03.23 | TRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update | 347 | GlobeNewswire (Europe) | SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development... ► Artikel lesen | |
| 08.03.23 | Sovos Brands, Inc.: Sovos Brands Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Provides 2023 Guidance | 557 | GlobeNewswire (Europe) | FY 2022 Net Sales and Adjusted EBITDA1 Exceed Previously Provided GuidanceFY 2023 Guidance Demonstrates Continued Strong Momentum on Top and Bottom Line LOUISVILLE, Colo., March 08, 2023 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| 08.03.23 | electroCore, Inc.: electroCore Announces Fourth Quarter and Full Year 2022 Financial Results | 199 | GlobeNewswire (Europe) | Record full year 2022 net sales of $8.6 million increased 58% over $5.5 million for full year 2021 Company to host conference call and webcast today, March 8, 2023 at 4:30pm EST ROCKAWAY, N.J., March... ► Artikel lesen | |
| 08.03.23 | Hudson Technologies Reports Fourth Quarter Revenue Growth of 26%; Record Full Year 2022 Revenue of $325.2 Million | 372 | GlobeNewswire (Europe) | WOODCLIFF LAKE, N.J., March 08, 2023 (GLOBE NEWSWIRE) -- Hudson Technologies, Inc. (NASDAQ: HDSN) announced results for the fourth quarter and year ended December 31, 2022. For the quarter ended December... ► Artikel lesen | |
| 08.03.23 | Noodles & Company Announces Fourth Quarter and Full Year 2022 Financial Results | 235 | GlobeNewswire (Europe) | Fourth Quarter 2022 Company-Owned Comparable Restaurant Sales Increase 10.2%; Significant Expansion of Operating Margin and Restaurant Contribution Margin Compared to Fourth Quarter 2021 BROOMFIELD... ► Artikel lesen | |
| 08.03.23 | Red Violet, Inc.: Red Violet Announces Fourth Quarter and Full Year 2022 Financial Results | 265 | GlobeNewswire (Europe) | Fourth Quarter Revenue Increased 16% to $13.1 Million Producing $4.4 Million of Cash Flow from Operations Full Year 2022 Revenue Increased 21% to $53.3 Million Generating Net Income of $0.6 Million... ► Artikel lesen | |
| 08.03.23 | Jasper Therapeutics Reports Fiscal 2022 Financial Results and Provides a Business Update | 405 | GlobeNewswire (Europe) | Announced Expansion of Briquilimab (formerly known as JSP191) Development Strategy to Include Chronic Spontaneous UrticariaPresentation of Key Briquilimab Clinical Data, Including Initial Results in... ► Artikel lesen | |
| 08.03.23 | Nephros, Inc.: Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results | 363 | GlobeNewswire (Europe) | Full-Year Net Revenue of $10 Million and Fourth Quarter Net Revenue of $2.6 Million SOUTH ORANGE, NJ, March 08, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Nephros, Inc. (Nasdaq: NEPH), a leading... ► Artikel lesen | |
| 08.03.23 | Profire Energy, Inc.: Profire Energy Reports Financial Results for Fourth Quarter and Full Fiscal Year 2022 | 313 | GlobeNewswire (Europe) | LINDON, Utah, March 08, 2023 (GLOBE NEWSWIRE) -- Profire Energy, Inc. (NASDAQ: PFIE), a technology company (the "Company") that provides solutions which enhance the efficiency, safety, and reliability... ► Artikel lesen | |
| 08.03.23 | Kronos Worldwide, Inc. Reports Fourth Quarter 2022 Results | 405 | GlobeNewswire (Europe) | Dallas, Texas, March 08, 2023 (GLOBE NEWSWIRE) -- Kronos Worldwide, Inc. (NYSE:KRO) today reported a net loss of $19.9 million, or $.18 per share, in the fourth quarter of 2022 compared to net income... ► Artikel lesen |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| GAMESTOP | 3.292 |
| EVOTEC | 2.632 |
| TUI | 2.073 |
| NEL | 1.325 |
| BAYER | 1.145 |
| PLUG POWER | 1.138 |
| NVIDIA | 1.134 |
| RHEINMETALL | 1.058 |
| AMC ENTERTAINMENT | 1.034 |
| DEUTSCHE BANK | 955 |
| SIEMENS ENERGY | 932 |
| RENK GROUP | 873 |
| REDCARE PHARMACY | 727 |
| COMMERZBANK | 723 |
| HEIDELBERGER DRUCK | 699 |
| ALIBABA | 675 |
| VOLKSWAGEN | 668 |
| E.ON | 617 |
| BARRICK GOLD | 610 |
| BYD | 591 |
| RWE | 585 |
| SIEMENS | 563 |
| TESLA | 562 |
| DEUTSCHE LUFTHANSA | 559 |
| AIXTRON SE | 554 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
